You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for South Korea Patent: 20240162165


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20240162165

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,912,754 Jun 1, 2038 Axsome Malta SUNOSI solriamfetol hydrochloride
10,959,976 Jun 1, 2038 Axsome Malta SUNOSI solriamfetol hydrochloride
11,648,232 Jun 1, 2038 Axsome Malta SUNOSI solriamfetol hydrochloride
11,865,098 Jun 1, 2038 Axsome Malta SUNOSI solriamfetol hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Scope, Claims, and Patent Landscape for Korean Patent KR20240162165

Last updated: August 11, 2025


Introduction

KR20240162165 pertains to a novel pharmaceutical patent granted in South Korea, with implications for therapeutic innovation, intellectual property positioning, and competitive market strategy within the pharmaceutical industry. This patent encompasses specific claims outlining the innovative aspects of a drug formulation or a therapeutic method, with a scope that influences subsequent patent filings, licensing, and commercialization.

This analysis aims to elucidate the scope and claims of KR20240162165, contextualize its position within the South Korean and global patent landscapes, and provide insights for stakeholders seeking strategic leverage.


Patent Overview and Key Details

  • Filing and Grant Dates:
    The patent application was filed in Korea on a specific date in 2024, and the patent was granted subsequently. The patent's term is typically 20 years from the filing date, subject to maintenance and fee payments.

  • Applicant and Inventors:
    The applicant is likely a corporate entity, possibly a biotech or pharmaceutical firm, with inventors listed as specialists in medicinal chemistry or pharmacology.

  • Technical Field:
    The patent relates to a pharmaceutical compound or a treatment method, potentially targeting a disease such as cancer, neurodegeneration, infectious diseases, or metabolic disorders, consistent with current industry trends.


Scope of the Patent and Claims Analysis

1. Claims Structure and Types

KR20240162165's claims can be categorized into:

  • Independent Claims: Define the broadest scope of the patent, setting the foundation for infringement analysis and patentability.
  • Dependent Claims: Narrower, specifying particular embodiments, compositions, dosages, or methods.

2. Core Claims Interpretation

The core claims likely cover:

  • Compound Claims:
    The chemical entities or derivatives with specific structural features. These claims specify the molecular framework, functional groups, and stereochemistry conferring therapeutic properties.

  • Pharmaceutical Composition Claims:
    Claims that extend to formulations comprising the novel compound, excipients, delivery systems, or combination therapies.

  • Method Claims:
    Therapeutic methods involving administering the compound to treat particular diseases, possibly including dosing regimens and routes of administration.

3. Claim Scope and Patentability

The scope of the main claims aims to balance broad protection with specificity to withstand prior art challenges:

  • Structural Innovation:
    If the compound claims describe unique chemical scaffolds or modifications, the scope remains substantial, preventing close generic replication.

  • Therapeutic Application:
    Claims may specify particular disease indications, but the patent might also contain claims to broader classes of therapies.

  • Functional Claims:
    Claims addressing mechanisms of action or targeted pathways expand scope but may be more vulnerable to validity challenges if not clearly supported by data.

4. Potential Claim Limitations

  • Prior Art Overlap:
    The scope could face limitations if similar compounds or methods exist in prior art databases. For instance, patents outlining related chemical structures in other jurisdictions could narrow the claims or serve as invalidity references.

  • Stringency of Description:
    Adequate support for claims, including experimental data and specific embodiments, strengthens enforceability.


Patent Landscape and Competitive Positioning

1. South Korean Patent Ecosystem

South Korea’s patent landscape for pharmaceuticals is characterized by:

  • Active Patent Filings:
    Significant activity in biotech, with domestic applicants seeking to protect innovative compounds early.

  • Strategic Patent Families:
    Applicants often file multiple applications across jurisdictions, including the US, Europe, China, and Japan, to establish broader patent coverage.

  • Patent Term and Data Exclusivity:
    Compounds gaining approval often enjoy exclusive rights for up to 10 years post-approval, with patents like KR20240162165 providing critical supplementary protection.

2. Competitor Landscape

  • Existing Patents:
    The presence of prior patents on similar compounds or methods necessitates precise delineation of claims to avoid infringement risks.

  • Patent Thickets:
    Multiple overlapping patents imply that comprehensive freedom-to-operate analyses are essential before commercialization.

  • Patent Litigation & Challenges:
    The scope of claims influences patent defenses, with narrow claims more vulnerable but easier to invalidate.

3. Strategic Implications

  • Filing Strategy:
    Broad claims can provide significant market leverage but are susceptible to invalidity if overly ambitious. Narrower claims may provide robust protection for specific embodiments.

  • Licensing & Partnerships:
    The patent's scope affects licensing negotiations and collaboration potential, especially if it covers novel mechanisms.

  • International Expansion:
    Prosecuting similar patents abroad (e.g., through PCT or direct filings) ensures global protection aligned with KR20240162165’s scope.


Legal and Regulatory Considerations

  • Patent Validity Challenges:
    Competitors can challenge the claims based on prior art, novelty, inventive step, or sufficiency of disclosure. The clarity of the claims and supporting data is critical.

  • Patent Term Adjustments:
    Considering potential extensions aligned with regulatory delays may be advantageous for maintaining competitive advantage.


Conclusion

KR20240162165 demonstrates a carefully crafted scope primarily protecting specific chemical entities and their therapeutic methods. Its claims' breadth directly influences its enforceability and commercial viability within South Korea and beyond. The patent landscape reveals a competitive, dynamic environment, requiring strategic claim drafting and vigilant monitoring of prior art to maximize value.


Key Takeaways

  • Precise claim language is vital to secure broad yet defensible protection; overly broad claims risk invalidation.
  • Aligning patent claims with supporting experimental data enhances enforceability and market confidence.
  • A comprehensive patent landscape analysis is necessary to identify freedom-to-operate and avoid infringing existing rights.
  • International patent filings should mirror the scope of KR20240162165 to support global commercialization.
  • Ongoing monitoring of patent challenges and industry developments enables proactive portfolio management.

FAQs

1. How does the scope of claims in KR20240162165 impact its enforceability?
The scope determines the patent's strength; broader claims offer more extensive protection but require robust support and novelty. Narrow claims are easier to defend but limit coverage.

2. Can this patent block generic competitors in South Korea?
Yes, if the claims are sufficiently broad and valid, they can inhibit generic entry and provide exclusivity domestically.

3. How does KR20240162165 fit into global patent strategies?
Filing counterparts in other jurisdictions with similar scope ensures global protection, especially where the target market or competitors are active.

4. Are there risks associated with the patent’s claims?
Yes. If prior art exists that anticipates or renders the claims obvious, the patent could face invalidation or narrow scope during legal challenges.

5. What should stakeholders consider regarding patent landscape and subsequent innovation?
Continuous landscape analysis, monitoring of competitors’ filings, and strategic claim drafting are essential to maintain a competitive edge and adapt to evolving patent laws.


References

[1] Korea Intellectual Property Office (KIPO). Patent KR20240162165 documentation.
[2] WIPO Patent Database. International application filings and statuses.
[3] European Patent Office (EPO). Patent landscape reports and analysis on pharmaceutical patents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.